Peginterferon is preferable to entecavir for prevention of unfavourable events in patients with HBeAg-positive chronic hepatitis B: A five-year observational cohort study
| Image |  |
|---|---|
| Description | scientific article published in November 2017 |
| Author/s |
author: Peng Hu |
| Publication date | November 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |